Search Within

Benjamin Heath Durham

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (13)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. Hematologic Malignancies, Division of (31)
  4. Solid Tumor Oncology Division (31)
  5. Executive Committee, Center for Hematologic Malignancies (30)
  6. GSK Faculty (30)

More Groups

People
  1. Omar Abdel-Wahab (30)
  2. Eli Diamond (23)
  3. David Hyman (20)
  4. Raajit Rampal (11)
  5. Gary Ulaner (10)
  6. Mario Lacouture (9)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Blood (9)
  2. Pediatric Blood and Cancer (3)
  3. Cancer Discovery (2)
  4. Journal of Clinical Investigation (2)
  5. Laboratory Investigation (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Nature Publishing Group (4)
  3. American Association for Cancer Research (3)
  4. Wiley Periodicals, Inc (3)
  5. American Society for Clinical Investigation (2)
  6. Nature Research (2)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Hershkovitz-Rokah, O.; Abdel-Wahab, O.; Yabe, M.; Chung, Y. R.; Itchaki, G.; Ben-Sasson, M.; Asher-Guz, V. A.; Groshar, D.; Doe-Tetteh, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Impaired proteolysis of noncanonical RAS proteins drives clonal hematopoietic transformation
    Journal Article

    Chen, S.; Vedula, R. S.; Cuevas-Navarro, A.; Lu, B.; Hogg, S. J.; Wang, E.; Benbarche, S.; Knorr, K.; Kim, W. J.; Stanley, R. F.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Impaired RAS proteolysis drives clonal hematopoietic transformation
    Meeting Abstract

    Chen, S.; Vedula, R. S.; Castel, P.; Cuevas Navarro, A.; Hogg, S. J.; Wang, E.; Mi, X.; Benbarche, S.; Knorr, K.; Kim, W. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
    Journal Article

    Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; more...
    Cell (2021)

    Fulltext@MSK | Save
  • Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis
    Journal Article

    Liu, B.; Liu, Z.; Chen, S.; Ki, M.; Erickson, C.; Reis-Filho, J. S.; Durham, B. H.; Chang, Q.; de Stanchina, E.; Sun, Y.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • Neurologic and oncologic features of Erdheim-Chester disease: A 30-patient series
    Journal Article

    Bhatia, A.; Hatzoglou, V.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Yabe, M.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save